...
首页> 外文期刊>Antiviral Research >Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells
【24h】

Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells

机译:靛玉红衍生物对甲型流感病毒(H5N1)感染的原代人外周血巨噬细胞和肺泡上皮细胞的抗炎和抗病毒作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Human disease caused by highly pathogenic avian influenza A (HPAI) (H5N1) is associated with fulminant viral pneumonia and mortality rates in excess of 60%. Acute respiratory syndrome (ARDS) has been found to be the most severe form of acute lung injury caused by H5N1 virus infection while cytokine dys-regulation and viral replication are thought to contribute to its pathogenesis. In this study, the antiviral and anti-inflammatory effects of two indirubin derivatives: indirubin-3'-oxime (IM) and E804 on primary human peripherial blood-derived macrophages and type-I like pneumocytes (human alveolar epithelial cells) during influenza A (H5N1) virus infection were investigated. We found that both of the indirubin derivatives strongly suppress the pro-inflammatory cytokines including IP-10 (CXCL10), one of the key factors which contribute to the lung inflammation during H5N1 virus infection. In addition, we also demonstrated that the indirubin derivative delays the virus replication in the primary cell culture models. Our results showed that indirubin derivatives have a potential to be used as an adjunct to antiviral therapy for the treatment of severe human H5N1 disease.
机译:高致病性禽流感(HPAI)(H5N1)引起的人类疾病与暴发性病毒性肺炎有关,死亡率超过60%。急性呼吸综合征(ARDS)被发现是由H5N1病毒感染引起的最严重的急性肺损伤形式,而细胞因子的异常调节和病毒复制被认为是其发病机理的原因。在这项研究中,两种靛玉红衍生物:靛红3'-肟(IM)和E804对人类外周血来源的巨噬细胞和I型肺炎细胞(人肺泡上皮细胞)的抗病毒和抗炎作用(H5N1)病毒感染进行了调查。我们发现,两种靛玉红衍生物都强烈抑制包括IP-10(CXCL10)在内的促炎细胞因子,这是导致H5N1病毒感染期间肺部炎症的关键因素之一。此外,我们还证明了靛玉红衍生物延缓了原代细胞培养模型中的病毒复制。我们的结果表明,靛玉红衍生物有潜力用作抗病毒治疗的辅助手段,以治疗严重的人类H5N1疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号